DVAX
Dynavax Technologies Corp
Price:  
10.87 
USD
Volume:  
1,116,248.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-83.8%
Upside

As of 2025-12-19, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 1.76 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.87 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -83.8%.

The range of the Relative Valuation is (3.51) - 10.88 USD.

Range Selected
Trailing P/E multiples 9.5x - 17.2x 13.4x
Forward P/E multiples 17.4x - 31.4x 24.4x
Fair Price (3.51) - 10.88 1.76
Upside -132.3% - 0.1% -83.8%
10.87 USD
Stock Price
1.76 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2025-12-18 -29.41
2025-12-17 -29.19
2025-12-16 -29.16
2025-12-15 -29.35
2025-12-12 -29.22
2025-12-11 -29.38
2025-12-10 -29.49
2025-12-09 -29.46
2025-12-08 -29.68
2025-12-05 -29.46
2025-12-04 -29.65
2025-12-03 -29.68
2025-12-02 -29.44
2025-12-01 -28.98
2025-11-28 -30.76
2025-11-26 -30.92
2025-11-25 -31.03
2025-11-24 -30.95
2025-11-21 -30.25
2025-11-20 -29.22
2025-11-19 -29.90
2025-11-18 -30.38
2025-11-17 -30.14
2025-11-14 -29.92
2025-11-13 -30.19
2025-11-12 -30.46
2025-11-11 -30.49
2025-11-10 -29.87
2025-11-07 -29.30
2025-11-06 -29.73
2025-11-05 -27.87
2025-11-04 -27.19
2025-11-03 -27.57
2025-10-31 -27.76
2025-10-30 -28.14
2025-10-29 -27.87
2025-10-28 -28.30
2025-10-27 -28.38
2025-10-24 -28.08
2025-10-23 -27.57
2025-10-22 -27.46
2025-10-21 -27.38
2025-10-20 -27.23
2025-10-17 -26.59
2025-10-16 -26.51
2025-10-15 -26.87
2025-10-14 -26.59
2025-10-13 -27.08
2025-10-10 -26.95
2025-10-09 -28.00